Stay updated with breaking news from Codexis Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
REDWOOD CITY, Calif., Oct. 31, 2023 -- Codexis, Inc. , a leading enzyme engineering company, today announced that management will participate in four upcoming investor conferences. The Jefferies...
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) was the recipient of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 2,520,000 shares, an increase of 7.2% from the September 30th total of 2,350,000 shares. Based on an average daily trading volume, of 1,020,000 shares, […]
/PRNewswire/ -- The industrial enzymes market size is forecasted to increase by USD 2,190.59 million from 2022 to 2027, at a CAGR of 6.26%, according to the...
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) has earned a consensus rating of “Moderate Buy” from the six research firms that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 1-year target price among […]
StockNews.com lowered shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a report published on Thursday. A number of other analysts also recently issued reports on CDXS. TD Cowen downgraded shares of Codexis from an outperform rating to a market perform rating and reduced their price target for […]